green
Positive treatment
6.5 score
Treatment trajectory · 1998 → 2026 · click a year to view as-of
1998
2012
2026
Top citers, strongest first. 31 distinct citers.
How cited ↗
cited
Cited "see"
Cunningham v. Haroona
See Merrell Dow Pharm., Inc. v. Havner, 953 S.W.2d 706, 714-15 (Tex.1997), cert. denied, 523 U.S. 1119 , 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998); see also Faust v. BNSF Ry.
cited
Cited "see"
Smith v. KELLY-MOORE PAINT CO., INC.
See Merrell Dow Pharm., Inc. v. Havner, 953 S.W.2d 706, 714 (Tex.1997), ce rt. denied, 523 U.S. 1119 , 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998); Georgia-Pac.
cited
Cited "see"
In Re the Expunction of J.A.
See Merrell Dow Pharmaceuticals, Inc. v. Havner, 953 S.W.2d 706, 711 (Tex.1997), cert. denied, 523 U.S. 1119 , 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998).
discussed
Cited "see"
City of Houston v. Fletcher
Southwest Key Program, Inc. v. Gil-Perez, 81 S.W.3d 269, 274 (Tex.2002); Garza v. Alviar, 395 S.W.2d 821, 823 (Tex.1965); see Merrell Dow Pharmaceuticals, Inc. v. Havner, 953 S.W.2d 706, 711 (Tex.1997), cert. den’d, 523 U.S. 1119 , 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998).
discussed
Cited "see"
Primrose Operating Co., Inc. v. Senn
Southwest Key Program, Inc. v. Gil-Perez, 81 S.W.3d 269, 274 (Tex.2002); Garza v. Alviar, 395 S.W.2d 821, 823 (Tex.1965); see Merrell Dow Pharmaceuticals, Inc. v. Hamer, 953 S.W.2d 706, 711 (Tex.1997), cert. den’d, 523 U.S. 1119 , 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998).
discussed
Cited "see"
Cannon v. Sun-Key Oil Co., Inc.
Southwest Key Program, Inc. v. Gil-Perez, 81 S.W.3d 269, 274 (Tex.2002); Garza v. Alviar, 395 S.W.2d 821, 823 (Tex.1965); see Merrell Dow Pharmaceuticals, Inc. v. Havner, 953 S.W.2d 706, 711 (Tex.1997), cert. den’d, 523 U.S. 1119 , 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998).
discussed
Cited "see"
Ellis v. City of Dallas
Southwest Key Program, Inc. v. Gil-Perez, 81 S.W.3d 269, 274 (Tex.2002); Garza v. Alviar, 395 S.W.2d 821, 823 (Tex.1965); see Merrell Dow Pharmaceuticals, Inc. v. Hamer, 953 S.W.2d 706, 711 (Tex.1997), cert, den’d, 523 U.S. 1119 , 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998).
discussed
Cited "see"
Soldo v. Sandoz Pharmaceuticals Corp.
See [Merrell Dow Pharm., Inc. v.] Havner, 953 S.W.2d [706], 718, 724 [Tex. 1997], cert. denied, [ 523 U.S. 1119 , 118 S.Ct. 1799 , 140 L.Ed.2d 939 ] (1998).”) 8 *539 54.Similarly, the Court of Appeals for the Third Circuit and district courts therein have held that adverse event reporting system data are not a legitimate basis for causation opinions involving pharmaceutical products.
cited
Cited "see"
Elgaghil v. Tarrant County Junior College
See Merrell Dow Pharm., Inc. v. Havner, 953 S.W.2d 706, 711 (Tex.1997), cert. denied, 523 U.S. 1119 , 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998); Moore, 981 S.W.2d at 269 .
cited
Cited "see"
Amerada Hess Corp. v. Wood Group Prod.
See Merrell Dow Pharmaceuticals, Inc. v. Havner, 953 S.W.2d 706, 711 (Tex.1997), cert. denied, 528 U.S. 1119 , 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998).
cited
Cited "see"
Nowroozi, Michael v. Strozier, Scott, Sam Stiefel, Nancy Walker & Tom Burslem
See Merrill Dow Pharm., Inc. v. Havner , 953 S.W.2d 706, 711 (Tex.1997), cert. denied , 523 U.S. 1119 , 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998).
discussed
Cited "see"
Texas Workers' Compensation Insurance Fund v. Lopez
Robinson, 923 S.W.2d at 557 ; see Merrell Dow Pharm. v. Havner, 953 S.W.2d 706, 714 (Tex.1997), cert. denied, 523 U.S. 1119 , 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998); see also Garcia, 974 S.W.2d at 85 .
discussed
Cited "see"
Robinson v. Warner-Lambert & Old Corner Drug
See Merrell Dow Pharmaceuticals, Inc. v. Havner, 953 S.W.2d 706, 711 (Tex.1997), ce rt. denied, — U.S. —, 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998); Connell v. Connell, 889 S.W.2d 534, 538 (Tex.App.—San Antonio 1994, writ denied).
cited
Cited "see"
Stephen L. Hopkins, Sr. v. Robert C. Kuehm
See Merrell Dow Pharmaceuticals, Inc. v. Havner , 953 S.W.2d 706, 711 (Tex. 1997), cert. denied , 118 S. Ct. 1799 (1998); Jackson , 979 S.W.2d at 70-71 ; Tex. R.
cited
Cited "see"
Stephen L. Hopkins, Sr. v. Robert C. Kuehm
See Merrell Dow Pharmaceuticals, Inc. v. Havner , 953 S.W.2d 706, 711 (Tex. 1997), cert. denied , 118 S. Ct. 1799 (1998); Jackson , 979 S.W.2d at 70-71 ; Tex. R.
cited
Cited "see"
Heart of Texas Produce Company, Inc. v. Mary Mahaffey
See Merrell Dow Pharmaceuticals, Inc. v. Havner , 953 S.W.2d 706, 711 (Tex. 1997), cert. denied , 118 S.Ct. 1799 (1998); Jackson , 979 S.W.2d at 70-71 ; Tex. R.
discussed
Cited "see"
Mireles v. Texas Department of Public Safety
(2×)
See Merrell Dow Pharm., Inc. v. Havner, 953 S.W.2d 706, 711-12 (Tex.1997) (unreliable scientific testimony admitted without objection is "no evidence"), cert. denied, ___ U.S. ___, 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998); cf. Emerson v. State, 880 S.W.2d 759, 764-65 (Tex.Crim.
discussed
Cited "see"
Knox v. Taylor
See Merrell Dow Pharmaceuticals, Inc. v. Hamer, 953 S.W.2d 706, 711 (Tex.1997), cert. denied, — U.S.-, 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998); Juliette Fowler Homes, Inc. v. Welch Assoc., Inc., 793 S.W.2d 660 , 666 n. 9 (Tex.1990).
cited
Cited "see"
Lampasas v. Spring Center, Inc.
See Merrell Dow Pharmaceuticals, Inc. v. Havner, 953 S.W.2d 706, 711 (Tex.1997), cert. denied, — U.S. -, 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998).
cited
Cited "see"
Isbell v. Ryan
See Merrell Dow Pharmaceuticals, Inc. v. Havner, 953 S.W.2d 706, 711 (Tex.1997), cert. denied, — U.S. —, 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998).
discussed
Cited "see"
Lisbeth L. Garratt v. John S. Walker, Doing Business as John S. Walker, Dmd
(2×)
See Mattei v. Mattei, 126 F.3d 794, 805-06 (6th Cir.1997), ce rt. denied, — U.S. -, 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998).
cited
Cited "see"
Whole Foods Market Southwest, Inc. v. Tijerina
See Merrell Dow Pharmaceuticals, Inc. v. Havner, 953 S.W.2d 706, 711 (Tex.1997), ce rt. denied, — U.S.-, 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998).
discussed
Cited "see, e.g."
Acadia Healthcare Co. v. Horizon Health Corp.
See, e.g., Merrell Dow Pharm., Inc. v. Havner, 953 S.W.2d 706, 714 (Tex.1997) ("[A]n expert’s testimony is unreliable even when the underlying data are sound if the expert draws conclusions from that data based on flawed methodology.’’), cert. denied, 523 U.S. 1119 , 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998). .No objection is required to argue on appeal that, on the face of the record, the testimony is conclusory and speculative and therefore lacks probative value.
discussed
Cited "see, e.g."
Myers v. Walker
Weirich v. Weirich, 833 S.W.2d 942, 945 (Tex.1992); In re King’s Estate, 150 Tex. 662 , 244 S.W.2d 660 (Tex.1951); see also Merrell Dow Pharmaceuticals, Inc. v. Havner, 953 S.W.2d 706, 711 (Tex.1997), cert. den’d, 523 U.S. 1119 , 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998).
discussed
Cited "see, e.g."
Christian Academy of Abilene v. City of Abilene
Juliette Fowler Homes, Inc. v. Welch Associates, Inc., 793 S.W.2d 660 (Tex.1990); In re King’s Estate, 150 Tex. 662 , 244 S.W.2d 660 (1951); see also Merrell Dow Pharmaceuticals, Inc. v. Havner, 953 S.W.2d 706, 711 (Tex.1997), cert. den’d, 523 U.S. 1119 , 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998).
discussed
Cited "see, e.g."
Wright v. Bowie Memorial Hospital
(2×)
See, e.g., Merrell Dow Pharms., Inc. v. Havner, 953 S.W.2d 706, 711-12 (Tex. 1997), cert. denied, 523 U.S. 1119 , 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998); Duff v. Yelin, 751 S.W.2d 175, 176 (Tex.1988).
discussed
Cited "see, e.g."
In Re DS
EVID. 702; see also Merrell Dow Pharms., Inc. v. Havner, 953 S.W.2d 706, 712 (Tex.1997), cert. denied, 523 U.S. 1119 , 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998); Lincoln Property Co. v. DeShazo, 4 S.W.3d 55, 58 (Tex.App.-Fort Worth *529 1999, pet. denied).
discussed
Cited "see, e.g."
In the Interest of D.S.
EVID. 702; see also Merrell Dow Pharms., Inc. v. Havner, 953 S.W.2d 706, 712 (Tex.1997), cert. denied, 523 U.S. 1119 , 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998); Lincoln Property Co. v. DeShazo, 4 S.W.3d 55, 58 (Tex.App.—Fort Worth 1999, pet. denied).
cited
Cited "see, e.g."
Weiss v. Mechanical Associated Services, Inc.
Mary’s L.J. at 419; see also Merrell Dow Pharms., Inc. v. Havner, 953 S.W.2d 706, 711 (Tex.1997), cert, denied, - U.S. -, 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998).
cited
Cited "see, e.g."
22 Employee Benefits Cas. 1765, 98 Cal. Daily Op. Serv. 6468, 98 Cal. Daily Op. Serv. 6892, 98 Daily Journal D.A.R. 9544, Pens. Plan Guide (Cch) P 23947e Gary Emard v. Hughes Aircraft Company, a Corporation Metropolitan Life Insurance Company, a Corporation Alex Stencel
See, e.g., Mattei v. Mattei, 126 F.3d 794 , 796 n. 2, 809 (6th Cir.1997), cert. denied, --- U.S. ----, 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998); Brandon v. Travelers Ins.
cited
Cited "see, e.g."
Emard v. Hughes Aircraft Co.
See, e.g., Mattei v. Mattei, 126 F.3d 794 , 796 n. 2, 809 (6th Cir.1997), cert. denied, — U.S. -, 118 S.Ct. 1799 , 140 L.Ed.2d 939 (1998); Brandon v. Travelers Ins.
Retrieving the full opinion text from the archive…
Hussein YOUSSEF, et ux.
v.
Morrison ENTITY
v.
Morrison ENTITY
No. 97-1518.
Supreme Court of the United States.
May 18, 1998.
Published
Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.